990 related articles for article (PubMed ID: 32977128)
1. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
[TBL] [Abstract][Full Text] [Related]
2. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
[TBL] [Abstract][Full Text] [Related]
6. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Naymagon L; Zubizarreta N; Feld J; van Gerwen M; Alsen M; Thibaud S; Kessler A; Venugopal S; Makki I; Qin Q; Dharmapuri S; Jun T; Bhalla S; Berwick S; Christian K; Mascarenhas J; Dembitzer F; Moshier E; Tremblay D
Thromb Res; 2020 Dec; 196():99-105. PubMed ID: 32853982
[TBL] [Abstract][Full Text] [Related]
7. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
[TBL] [Abstract][Full Text] [Related]
8. The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients.
Fu Y; Liu Y; Chen S; Jin Y; Jiang H
Medicine (Baltimore); 2018 Nov; 97(47):e13232. PubMed ID: 30461624
[TBL] [Abstract][Full Text] [Related]
9. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
10. Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.
Creel-Bulos C; Liu M; Auld SC; Gaddh M; Kempton CL; Sharifpour M; Sniecinski RM; Maier CL; Nahab FB; Rangaraju S
Medicine (Baltimore); 2020 Nov; 99(46):e23186. PubMed ID: 33181697
[TBL] [Abstract][Full Text] [Related]
11. Plasma D-dimer value corrected by inflammatory markers in patients with SARS-CoV-2 infection: Its prognostic value in the diagnosis of venous thromboembolism.
Rueda-Camino JA; Sendín-Martín V; Joya-Seijo MD; Angelina-García M; Zamarro-García C; Gimena-Rodríguez FJ; Barba-Martín R
Med Clin (Barc); 2022 Mar; 158(6):265-269. PubMed ID: 34144801
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a D-Dimer Protocol for Detection of Venous Thromboembolism.
Karsy M; Azab MA; Harper J; Abou-Al-Shaar H; Guan J; Eli I; Brock AA; Ormond RD; Hosokawa PW; Gouripeddi R; Butcher R; Cole CD; Menacho ST; Couldwell WT
World Neurosurg; 2020 Jan; 133():e774-e783. PubMed ID: 31605841
[TBL] [Abstract][Full Text] [Related]
13. The Usefulness of the Combination of D-Dimer and Soluble Fibrin Monomer Complex for Diagnosis of Venous Thromboembolism in Psychiatric Practice: A Prospective Study.
Takeshima M; Ishikawa H; Ogasawara M; Komatsu M; Fujiwara D; Itoh Y; Wada Y; Omori Y; Ohta H; Mishima K
Vasc Health Risk Manag; 2021; 17():239-246. PubMed ID: 34054298
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching].
Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276
[TBL] [Abstract][Full Text] [Related]
15. Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
Nauka PC; Baron SW; Assa A; Mohrmann L; Jindal S; Oran E; Glazman-Kuczaj G; Southern WN; Chekuri S
Thromb Res; 2021 Mar; 199():82-84. PubMed ID: 33476901
[No Abstract] [Full Text] [Related]
16. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
17. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.
Engelen MM; Vandenbriele C; Balthazar T; Claeys E; Gunst J; Guler I; Jacquemin M; Janssens S; Lorent N; Liesenborghs L; Peerlinck K; Pieters G; Rex S; Sinonquel P; Van der Linden L; Van Laer C; Vos R; Wauters J; Wilmer A; Verhamme P; Vanassche T
Semin Thromb Hemost; 2021 Jun; 47(4):362-371. PubMed ID: 33893631
[TBL] [Abstract][Full Text] [Related]
18. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.
Kovářová M; Koller T; Štvrtinová V; Payer J
Endokrynol Pol; 2015; 66(6):474-9. PubMed ID: 26662645
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.
Cui S; Chen S; Li X; Liu S; Wang F
J Thromb Haemost; 2020 Jun; 18(6):1421-1424. PubMed ID: 32271988
[TBL] [Abstract][Full Text] [Related]
20. Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients.
Heerink JS; Gemen E; Oudega R; Geersing GJ; Hopstaken R; Kusters R
J Appl Lab Med; 2022 Mar; 7(2):444-455. PubMed ID: 34597379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
